SCHEMBL18322986

SCHEMBL18322986

CC(C)(C)[S+]([O-])/N=C1\C(CO)CCC12CCN(C(=O)O)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18322988 1.00 — —
SCHEMBL31184216 0.86 GPR119 (0.39) —
SCHEMBL20337394 0.86 GPR119 (0.39) —
SCHEMBL23826992 0.77 — —
SCHEMBL23826837 0.77 — —
SCHEMBL18319616 0.74 — —
SCHEMBL18319615 0.74 — —
SCHEMBL28900028 0.72 — —
SCHEMBL5895182 0.70 CRBN (0.32) —
SCHEMBL19641150 0.67 AVPR1A (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3310771-A1 COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 Novartis AG (CH) 2018-04-25 — — EP disclosed
WO-2016203405-A1 COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 NOVARTIS AG (CH) 2016-12-22 — — WO disclosed
Send feedback